Artemisia princeps is a familiar plant as a food substance and medicinal herb. In this study, we evaluated the effects of an ethanol extract of A. princeps (APE) on glucose uptake in differentiated L6 muscle cells. Treatment with APE elevated deoxyglucose uptake, and translocation of the insulin-responsive glucose transporter (GLUT4) to the plasma membrane in L6 myotubes occurred. The PI3K inhibitor LY294002 attenuated glucose uptake induced by APE. Phosphorylation of the Ser 473 residue of Akt was not observed, but phosphorylation of PI3K, Akt (Thr 308 ), and atypical PKC was. In addition, APE stimulated phosphorylation of AMP-activated protein kinase (AMPK) at a level similar to 5 0 -amino-5-imidazolecarboxamide-riboside (AICAR). These results indicate that APE stimulates glucose uptake by inducing GLUT4 translocation, which is in part mediated by combination of the PI3K-dependent atypical PKC pathway and AMPK pathways.
Artemisia princeps Pampan (Asteraceae) is an ingredient in kusa-mochi (also known as yomogi-mochi), a Japanese confectionery, to which it imparts its fresh, springlike fragrance and vivid green coloring. In Korea, it is used for making tteok (rice cakes), jeon (Korianstyle pancakes), ssuk kimchi, ssukguk (soup made with ssuk), and so forth. It is also used in traditional Asian medicine in the treatment of inflammation, diarrhea, and many circulatory disorders.
Insulin resistance is defined as reduced ability of tissues to respond to physiological levels of insulin. It is characteristic of non-insulin-dependent diabetes mellitus (NIDDM). Skeletal muscle constitutes the major mass of peripheral tissue, accounting for about 40% of total body mass and >30% of total energy expenditure, and it is the primary tissue responsible for postprandial uptake of glucose from blood. 1) One of the major factors regulating glucose uptake into muscle is the quantity of glucose transporter (GLUT) protein on the cell surface. In muscle cells and adipocytes, GLUT1 mediates basal and nonstimulated transport, whereas an insulin responsive GLUT, GLUT4, facilitates increased glucose transport in the presence of insulin. Hence, to survey for agents that increase glucose uptake by enhancing GLUT4 translocation is one of the major strategies for discovering new therapeutic agents for NIDDM. On this basis, we developed a non-radioisotopic, high-throughput enzymatic assay to evaluate glucose uptake in cultured skeletal muscle cells. 2) There is growing interest in natural sources of nutrients and health-promoting compounds. Using our method, we surveyed herbal extracts that promote uptake of 2-deoxyglucose (2DG) in cultured L6 myotubes, and discovered that an ethanol extract of A. princeps (APE) was a promising stimulator of glucose uptake. In the present study, we investigated to determine whether APE-stimulated glucose uptake is accompanied by translocation of GLUT4 in cultured skeletal muscle.
Materials and Methods
Plant material. A. princeps, harvested in Japan and marketed as a raw dried herbal material, was obtained from Mikuni (Osaka, Japan). The herbal plant (2.0 g) was extracted with ethanol (30 ml) at 5 C for 24 h and filtered through no. 2 paper filter (Toyo Advantech, Tokyo). The extract obtained was evaporated and dissolved in ethanol to yield a 1:1 fluid extract (1 ml of fluid extract is equivalent to 1,000 mg of dry whole plant), and stored at 4 C. The sample solvent was replaced by DMSO just before analysis. The 1:1 fluid extract obtained was 1.4% w/v dry matter.
Chemicals and reagents. Glucose-6-phosphate dehydrogenase (G6PDH), 2DG, 2-deoxyglucose-6-phosphate (2DG6P), and insulin y To whom correspondence should be addressed. Fax: +81-72-778-0892; E-mail: Yamamoto Norio@house-wf.co.jp * Present affiliation: Department of Bioscience, Fukui Prefectural University, 4-1-1 Matsuoka Kenjyojima, Eiheiji-cho, Yoshida-gun, Fukui 910-1195, Japan Abbreviations: AICAR, 5 0 -amino-5-imidazolecarboxamide-riboside; -MEM, -minimal essential medium; AMPK, AMP-activated protein kinase; APE, Artemisia princeps ethanol extract; aPKC, atypical protein kinase C; BSA, bovine serum albumin; 2DG6P, 2-deoxyglucose 6-phosphate; DMEM, Dulbecco's Modified Eagle's Medium; DMSO, dimethylsulfoxide; FBS, fetal bovine serum; GLUT, glucose transporter; 2DG, 2-deoxyglucose; G6PDH, glucose-6-phosphate dehydrogenase; IRS, insulin receptor substrate; KRPH, Krebs-Ringer-phosphate-Hepes; NIDDM, non-insulin-dependent diabetes mellitus; PDK1, phosphoinositide-dependent kinase-1 PI3K, phosphatidyl inositol 3 0 kinase; PKB, protein kinase B; PVDF, polyvinylidene difluoride; TEA, triethanolamine were purchased from Sigma-Aldrich (St. Louis, MO). Resazurin sodium salt and triethanolamine hydrochloride (TEA) were from Wako Pure Chemicals (Osaka, Japan). Diaphorase, ATP, and NADP were from Oriental Yeast (Tokyo). For western blot analysis, anti-GLUT4 goat IgG, anti-GLUT1 goat IgG, anti-IR rabbit IgG, anti-goat IgG, anti-p-PI3K goat IgG, and anti-rabbit IgG antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-Akt (Thr 308 ) rabbit IgG, anti-phospho-PKC/ rabbit IgG, anti-Akt rabbit IgG, and anti-AMPK rabbit IgG were from Cell Signaling Technology (Danvers, MA). Anti-phospho-Akt (Ser 473 ) rabbit IgG was from Sigma-Aldrich. Anti-PI3K mouse IgG, and anti-PKC mouse IgG were from BD Transduction Laboratories (San Jose, CA). All other reagents used were of the highest commercially available grade.
HPLC analysis of polyphenol profiles. The polyphenol profiles of APE were analyzed by an HPLC system, as previously described. 3) Briefly, ethanol extract was filtered through a Millex-LG 0.2-mm membrane filter (Millipore, Bedford, MA). The extract was analyzed by a Hitachi HPLC series D-7000 (Tokyo) equipped with Hitachi model D-7000 chromatography data station software and diode array detection system D7450 to monitor at all wavelengths from 200 to 600 nm. Chromatographic separation was carried out on a Capcell pak C18 UG120 (250 Â 4:0 mm i.d., S-5, 5 mm, Shiseido, Tokyo) by a gradient elution of 50 mM sodium phosphate (pH 3.3) containing either 10% v/v methanol (solution A) or 70% methanol (solution B). The gradient program was as follows: 100% solution A; 70% solution A for the following 15 min; 65% solution A for 20 min; 60% solution A for 20 min; 50% solution A for 5 min; and 0% solution A for the final 25 min. The flow rate was 1 ml/min, the injection volume was 10 ml, and the oven temperature was 35 C. Phenolic compound quantification was determined by the absorbance at 250 and at 320 nm recorded in the chromatograms relative to external standards or previously generated calibration curves in the system library.
Cell culture. L6 skeletal muscle cells and 3T3-L1 adipose cells were purchased from Dainippon Pharmaceuticals (Osaka, Japan). L6 myoblasts were cultured in -minimal essential medium (-MEM) supplemented with 10% heat-inactivated fetal bovine serum (FBS) at 37 C in 5% CO 2 . The cells were grown in a 96-well plate for the 2DG uptake assay and in a 35-mm diameter dish for western blot analysis. Differentiation of L6 myoblasts to myotubes was performed as previously described.
2) Briefly, cells were cultured in -MEM supplemented with 2% FBS and maintained in this medium postdifferentiation. Myotubes were used in experiments 5-7 d after differentiation. Differentiation of 3T3-L1 fibroblasts to adipocytes was performed as described previously. 4) Briefly, confluent cells in a 24-well culture plate were incubated for 2 d in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% FBS, 0.5 mM 3-isobutyl-1-methylxanthine, 1 mM dexamethasone, and 5 mg/ml of insulin. After differentiation, the medium was replaced every other day with DMEM containing 10% FBS and 5 mg/ml of insulin.
2-Deoxyglucose uptake assay. Glucose uptake was determined by non-radioisotopic, enzymatic fluorescence assay for 2DG uptake in cultured cells, as described previously. 2, 5) In brief, L6 myotubes in a 96-well format were incubated for 4 h in a medium containing herbal extract or DMSO (0.1% v/v) as vehicle control. After induction, the cells were washed twice with Krebs-Ringer-Phosphate-Hepes (KRPH) buffer containing 0.1% BSA, and 2DG uptake was initiated by incubation with KRPH buffer containing 1 mM 2DG and 0.1% BSA. After 20 min, the cells were washed twice with KRPH buffer containing 0.1% BSA, followed by the addition of 50 ml of 0.1 M NaOH, and the culture plate was heated at 85 C for 50 min. The component in the wells was neutralized by the addition of 50 ml of 0.1 M HCl, followed by the addition of 50 ml of 150 mM TEA buffer (pH 8.1). The cell lysate (10 ml) was transferred to a 96-well assay plate and incubated for 45 min with 100 ml of assay cocktail, which contained 50 mM KCl, 0.1 mM NADP, 20 units/ml of G6PDH, 0.2 units/ml of diaphorase, 5 mM resazurin sodium salt, and 50 mM TEA buffer (pH 8.1). The resorufin generated was measured with a plate reader (ex. 530 nm and em. 615 nm). A standard curve was generated by measuring 2DG6P standard solution in the wells of the assay plate. For the 3T3-L1 adipose cells (24 well format plate), cell lysate treated with 2DG was prepared in a 24-well format culture plate, and an aliquot was transferred to a 96-well plate for measurement of 2DG6P, as described above.
Western blot analysis. L6 myotubes were serum-starved for 18 h and treated with 5 mg/ml of APE for the indicated durations, and plasma membrane or whole cell lysate was prepared, as described previously. 6) In summary, proteins (5-20 mg) were separated with 7.5 or 10% SDS-PAGE gels and electrophoretically transferred to a polyvinylidene fluoride (PVDF) membrane. The membranes were blocked with Blocking-oneÔ (Nacalai Tesque, Kyoto, Japan) and washed with TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) 6 times. Antibodies were diluted in Can Get Signal Ò Immunoreaction Enhancer Solution (Toyobo, Osaka, Japan) and incubated overnight at 4 C. Membranes were incubated with primary antibody for 1 h at room temperature, and then incubated with secondary antibody conjugated to horseradish peroxidase at room temperature for 1 h. Antibody-bound proteins were visualized using Lumi-Light plus Western Blotting Substrate (Roche Applied Science, Mannheim, Germany) following the manufacturer's protocol.
Statistical analysis. Statistical significance was determined by analysis of variance (ANOVA), followed by the Tukey multiple comparison test (GraphPad Prism 5 for Windows Version 5.01, GraphPad Software). p-Values <0:05 were considered statistically significant.
Results

Polyphenol analysis
The polyphenolic profile of APE was analyzed using a HPLC system constructed for simultaneous determination of polyphenols in food stuffs (Table 1) . Comparison with the library in the HPLC system identified the presence of luteolin (20 nmol/ml in a 1:1 fluid extract), chlorogenic acid (33 nmol/ml), and protocatechuic acid (20 nmol/ml) in APE. 3,5-di-O-caffeoylquinic acid (380 nmol/ml), which was one of the major components, was analyzed by comparison with a standard chromatogram. A previous study reported that one of the flavones, eupatilin, is an active compound in A. princeps. 7, 8) We checked the amount of eupatilin in our APE as compared with standard compounds obtained from PhytoLab (Vestenbergsgreuth, Germany), and confirmed that our APE did not contain eupatilin. We could not identify some peaks because they were absent from our polyphenolic library data, but one of the unidentified a The phenolic content of APE was determined using an HPLC system constructed for simultaneous determination of polyphenols in foods.
3) The names of the compounds that were identifiable using this system are shown. b Quantities of protocatechuic acid, chlorogenic acid, and luteolin were calculated using previously generated calibration curves in the system library. c The quantity of 3,5-di-O-caffeoylquinic acid was calculated using the standard curve generated from an external standard. An unknown compound peak, thought to be a flavone (r.t., 84.0 min), with a spectrum similar to luteolin, was detected at a concentration comparable to luteolin.
peaks was assumed to be a flavone on the basis of its spectrum.
Effects of APE on 2DG uptake in L6 myotubes and 3T3-L1 adipocytes
Treatment of L6 myotubes with APE for 4 h resulted in dose-dependent increases in 2DG uptake, similarly to the insulin-stimulated cells (Fig. 1A) . APE increased 2DG uptake in 3T3-L1 adipocytes, too (Fig. 1B) . However, the high concentrations of APE (10 mg/ml for L6 cells and 5 mg/ml for 3T3L1 cells) tended to result in less activity. This suggests that the high concentration of extract affected the viability of the cells. Hence, in the following experiments, L6 cells were stimulated at a concentration of 5 mg/ml.
Effects of APE on GLUT4 translocation
To assess the potential activity of APE on glucose metabolism and insulin action, we first examined the effect of APE on the translocation of GLUT4 to plasma membrane, an essential step in inducible glucose uptake into muscle cells and adipocytes. The effects of APE on the translocation of the GLUT1 and GLUT4 isoforms were analyzed by western blot in L6 cells (Fig. 2) . APE raised plasma membrane levels of GLUT4 from 15 to 60 min. On the other hand, APE did not affect the level of GLUT1 in the plasma membrane. This suggests that GLUT4 translocation contributes to APE-stimulated glucose uptake.
Effects of PI3K inhibitor on APE-stimulated 2DG uptake
The phosphatidyl inositol 3 0 -kinase (PI3K) pathway plays a major regulatory role in the insulin action pathway, and PI3K inhibitors inhibit insulin-stimulated glucose uptake. We used LY294002, a potent and selective PI3K inhibitor, to examine the contribution of PI3K to APE-induced glucose uptake. As shown in Fig. 3 , the stimulatory effect of APE on glucose uptake was inhibited by 25 mM of LY294002, indicating that PI3K is a key molecule in APE-stimulated glucose uptake, but inhibition by LY294002 was not complete, although insulin-stimulated 2DG uptake was inhibited completely.
Effects of APE on the PI3K downstream pathway
Next we explored the effects of APE on two important downstream targets of the PI3K signaling pathway, serine/threonine kinase Akt, also known as protein kinase B (PKB), and atypical protein kinase C (aPKC). These two targets of PI3K have been found to play roles in insulin-stimulated GLUT4 translocation in muscle and fat cells. Cell lysate was immunoblotted with antibodies raised against p-PI3K, p-Akt (Thr 308 ), p-Akt (Ser 473 ), and p-PKC (Fig. 4) . Phosphorylation of PI3K, Akt (Thr 308 ), and aPKC was observed in cells stimulated with APE for 15 min, but APE did not induce phosphorylation of the Ser 473 residue of Akt. APE-stimulated phosphorylation decreased to control levels in the cells after 60 min. Insulin stimulated phosphorylation of all these kinases.
Effects of APE on AMPK phosphorylation
We also investigated to determine whether APE stimulates phosphorylation of AMPK, a stress kinase that has been found to regulate GLUT4 translocation. As A B Fig. 1 . Effects of APE on 2DG Uptake in L6 Myotubes (A) and 3T3-L1 Adipocytes (B). L6 myotubes were grown in a monolayer in a 96-well plate and 3T3-L1 adipocytes were grown in a monolayer in a 24-well plate, as described in ''Materials and Methods.'' Cells were treated with increasing doses of APE for 4 h prior to 2DG uptake assay. Cells were treated with DMSO (0.1% v/v) or insulin (100 nM) as negative and positive control respectively. 2DG uptake was measured for a period of 20 min. Values are the mean AE SD of triplicates. Different letters indicate statistically significant differences.
Ã The dose value of APE is expressed as the equivalent of dried herb. L6 myotubes were serum-starved for 18 h prior to treatment with APE at 5 mg/ml Ã for the indicated durations. A plasma membrane fraction was prepared from the cells, and western blot analysis was performed to detect GLUT4 and GLUT1. Cells treated with 100 nM insulin or 0.1% v/v DMSO for 15 min served as positive and negative control respectively. Values are the mean AE SE of three independent experiments.
Ã The dose value of APE is expressed as the equivalent of dried herb.
shown in Fig. 5 , APE-induced phosphorylation of AMPK was observed by western blot analysis at 60 min, at a level similar to that observed in AICARstimulated cells.
Discussion
In the present study, we found that an ethanol extract of A. princeps (APE) increased glucose uptake activity in cultured L6 myotubes and 3T3-L1 adipocytes. This increased activity was accompanied by stimulation of GLUT4 translocation to the cell surface in APEstimulated L6 myotubes via activation of both PI3K and its downstream factors, and AMPK. Peripheral resistance to insulin is a prominent feature of NIDDM. One of the major factors regulating glucose uptake into muscle is the quantity of GLUT protein on the cell surface. 1) Insulin resistance is believed to result from defects in insulin-post-receptor signals that induce translocation of GLUT4 to the plasma membrane. 9, 10) Hence, surveying for agents that increase glucose uptake via stimulation of GLUT4 translocation is one of the major strategies for discovering new therapeutic agents for NIDDM. We have developed a method of evaluating glucose uptake into cultured cells 2, 5) and have surveyed the herbal extracts that promote uptake of 2DG in cultured L6 myotubes. We found that APE promoted 2DG uptake into the cells. This is the first report that APE stimulates GLUT4 translocation and increases glucose uptake activity in insulin-sensitive peripheral tissues.
Recently, an anti-diabetic effect of Korean A. princeps in type-2 diabetic mice was reported. 7, 8) The active constituent is thought to be a flavone, eupatilin, which had a functional anti-diabetic effect by enhancing hepatic and plasma glucose metabolism. 8) Hence, we analyzed the amount of eupatilin in our APE by HPLC analysis, and confirmed that our APE did not contain eupatilin. The A. princeps used in the previous studies were variants cultivated in Korea, and may have had a different composition of phytochemicals than Japanese A. princeps. Furthermore, the anti-diabetic effects of Korean A. princeps appeared to be mediated through stimulation of glucokinase activity, inhibition of glucose-6-phosphatase activity in the liver, and enhanced pancreatic insulin secretion, 8) but the regulation of glucose uptake in muscle and adipose tissues through GLUT4 translocation was not examined in these previous studies.
The compound with the highest concentration in APE, 3,5-di-O-caffeoylquinic acid, did not promote glucose uptake at a concentration equivalent to its quantity in APE. The other chemicals identified by HPLC did not induce glucose uptake (data not shown). It has been reported that Artemisia plants contain -sitosterol and scopoletin.
11) TLC analysis revealed that our APE contained -sitosterol and scopoletin, but these compounds did not induce glucose uptake at concentrations equivalent to their levels in APE (data not shown). A. princeps contains sesquiterpenoid lactones 12, 13) and number of volatile chemicals. 14) Some individual components may have synergistic effects, while some particular components may have strong independent effects.
Insulin stimulates glucose uptake into muscle cells and adipocytes by inducing the redistribution of insulinresponsive GLUT4 from intracellular stores to the plasma membrane. Treatment with APE promoted translocation of GLUT4 to the plasma membrane of L6 myotubes. To determine the mechanisms of GLUT4 translocation and glucose uptake by APE, we examined the effects of APE on cellular signaling pathways known to modulate these processes. The ability of APE to induce 2DG uptake was inhibited by a potent and selective PI3K inhibitor, LY294002. Hence, the downstream action of PI3K on glucose uptake is thought to contribute to this upregulation, but the inhibition by LY294002 was not complete even though insulinstimulated 2DG uptake was inhibited completely. It is generally accepted that PI3K has an essential regulatory role in the insulin-signaling pathway, and that it is primarily activated through insulin receptor substrates, IRS-1 and IRS-2. It is further thought that downstream effectors PI3K, Akt, [15] [16] [17] [18] [19] and aPKC/ [20] [21] [22] [23] serve as major distal regulators of glucose transport in response to insulin. Hence, we examined to determine whether APE would activate these downstream effectors of the insulin-signaling pathway. Insulin stimulated the phosphorylation of PI3K, Akt (Thr 308 and Ser 473 ), and aPKC/ in L6 muscle cells. In comparison, APE stimulated the phosphorylation of PI3K, Akt (Thr 308 ), Fig. 3 . Effects of the PI3K Inhibitor LY294002 on APE-Induced 2DG Uptake. Differentiated L6 cells in a 96-well plate were treated with and without 25 mM LY294002 for 30 min. They were then incubated with APE or 100 nM insulin for 4 h. After incubation with stimuli, 2DG uptake was assayed as described in ''Materials and Methods.'' Values are the mean AE SD of tripricate. Different letters indicate statistically significant differences.
Ã The dose value of APE is expressed as the equivalent of dried herb. and aPKC/, but did not stimulate the phosphorylation of the Ser 473 residue of Akt. The PI3K/Akt pathway plays an important role in the metabolic effects of insulin. 24) L6 myotubes were serum-starved for 18 h prior to treatment with 5 mg/ml Ã of APE for 15 and 60 min. Whole-cell lysates were subjected to western blots to detect the phosphorylation status of PI3K, Akt, and aPKC/. Values are the mean AE SE of triplicates. Different letters indicate statistically significant differences.
phorylation. 28, 29) We suggest that the phosphorylation of the Ser 473 residue of Akt by APE is implicated in the activation of PDK2, but it is uncertain whether this activation of PDK2 takes part in the uptake of glucose. Similarly to Akt, another PDK1 substrate, the atypical aPKC/ family, has been implicated in GLUT4 transfer to the plasma membrane. 30) APE induced phosphorylation of aPKC/ and the Thr 308 residue of Akt, but did not induce phosphorylation of the Ser 473 residue of Akt. These results suggest that APE stimulates aPKC activity thorough the activation of PI3K. Phosphorylation of aPKC was observed transiently at 15 min, and returned to basal levels by 60 min. The observed GLUT4 translocation 15 min after APE-treatment suggests that transient activation of these pathways contributed to GLUT4 translocation.
In skeletal muscle, glucose transport is activated by distinct pathways mediated by insulin and muscle contraction. 31) AMPK regulates GLUT4-dependent glucose transport in response to diverse forms of cellar stress, including contraction, hypoxia, 32) and agents that disrupt the intracellular ATP:AMP ratio. 10) An early study using non-specific pharmacological activators such as AICAR, a compound taken up into skeletal muscle and metabolized by adenosine kinase to form 5-aminoimidazole-4-carboxamide-1--D-ribofluranotide, the monophosphorylated derivative that mimics the effect of AMP on AMPK, suggested that AMPK regulated glucose transport. 33) Treatment of skeletal muscle with AICAR in vitro increased glucose uptake, which was unaffected by inhibition of the insulindependent PI3-kinase pathway, 33, 34) mimicking the effect of muscle contraction to increase glucose transport. APE-and AICAR-stimulated cells showed similar levels of AMPK phosphorylation. Therefore, activation of AMPK by APE must also contribute to increases in glucose uptake via translocation of the GLUT4 protein, but the question remains which component of APE is the most effective inducer of AMPK. AMPK is regulated by the AMP:ATP ratio and upstream kinases, including calcium-dependent protein kinase kinase, or LKB1. [35] [36] [37] [38] [39] This suggests that APE contains a compound that modulates the cellular AMP:ATP ratio or an upstream kinase of AMPK.
In conclusion, APE facilitated glucose uptake in cultured muscle cells via GLUT4 translocation. The results of the present study indicate that A. princeps stimulated the PI3K-dependent aPKC pathway and the AMPK pathway and had insulin-mimetic activity, suggesting that an insulin-independent pathway is the major mechanism by which APE exerts anti-diabetic potential.
There is growing interest in natural sources of nutrients and health-promoting compounds. Although the active components and their precise mechanisms of action remain to be clarified, these promising in vitro results indicate a need for in vivo testing of A. princeps in diabetic animals. Moreover, the identification of active compounds in A. princeps might result in the discovery of promising new anti-diabetic molecules.
